AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Niagen Bioscience, Inc. Director's Dealing 2008

Oct 29, 2008

32418_dirs_2008-10-29_0d9cec29-6574-4e80-9667-7f94cdb69cd7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2008-10-20

Reporting Person: Black Sheep FLP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6225155	Direct

Footnotes

F1: These securities are owned by Black Sheep, F.L.P., a family limited partnership the sole co-general partners of which are Frank L. Jaksch, Jr. and Tricia A. Jaksch and the sole limited partners of which are Frank L. Jaksch, Jr., Tricia A. Jaksch and the Jaksch Family Trust UTD June 25, 2008, Frank L. Jaksch, Jr. and Tricia A. Jaksch Trustees.